Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

BACKGROUND: Oral fluoropyrimidine plus platinum is a standard first-line treatment for advanced gastric cancer (AGC). However, this treatment is problematic for AGC patients with massive ascites or inadequate oral intake. This study aimed at evaluating the efficacy and safety of modified oxaliplatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Osumi, Hiroki, Takahari, Daisuke, Chin, Keisho, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Suzuki, Takeshi, Ota, Yumiko, Nakayama, Izuma, Ooki, Akira, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260191/
https://ncbi.nlm.nih.gov/pubmed/30538499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S184665
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados